- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 513/04
Total number of patents in this class: 4290
10-year publication summary
|
266
|
307
|
330
|
307
|
299
|
287
|
308
|
325
|
303
|
163
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4751 |
89 |
| Merck Patent GmbH | 5729 |
75 |
| F. Hoffmann-La Roche AG | 7819 |
66 |
| Merck Sharp & Dohme LLC | 3736 |
66 |
| Boehringer Ingelheim International GmbH | 4493 |
60 |
| Janssen Pharmaceutica N.V. | 3162 |
59 |
| Takeda Pharmaceutical Company Limited | 2710 |
58 |
| Hoffmann-La Roche Inc. | 3796 |
57 |
| Genentech, Inc. | 4110 |
53 |
| Daiichi Sankyo Company, Limited | 1890 |
52 |
| BASF SE | 21308 |
47 |
| Achillion Pharmaceuticals, Inc. | 157 |
45 |
| Gilead Sciences, Inc. | 2226 |
45 |
| Amgen Inc. | 4429 |
44 |
| Novartis AG | 10251 |
43 |
| Dana-Farber Cancer Institute, Inc. | 2665 |
35 |
| Incyte Corporation | 1067 |
35 |
| FUJIFILM Corporation | 30516 |
34 |
| Sumitomo Chemical Company, Limited | 8968 |
33 |
| Abbvie Inc. | 1824 |
29 |
| Other owners | 3265 |